Literature DB >> 12391149

Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38.

Marina Lasa1, Sonya M Abraham, Christine Boucheron, Jeremy Saklatvala, Andrew R Clark.   

Abstract

The stress-activated protein kinase p38 stabilizes a number of mRNAs encoding inflammatory mediators, such as cyclooxygenase 2 (Cox-2). In HeLa cells the anti-inflammatory glucocorticoid dexamethasone destabilizes Cox-2 mRNA by inhibiting p38 function. Here we demonstrate that this effect is phosphatase dependent. Furthermore, in HeLa cells dexamethasone induced the sustained expression of mitogen-activated protein kinase phosphatase 1 (MKP-1), a potent inhibitor of p38 function. The inhibition of p38 and the induction of MKP-1 by dexamethasone occurred with similar dose dependence and kinetics. No other known p38 phosphatases were induced by dexamethasone, and other cell types which failed to express MKP-1 also failed to inhibit p38 in response to dexamethasone. The proinflammatory cytokine interleukin 1 (IL-1) induced MKP-1 expression in a p38-dependent manner and acted synergistically with dexamethasone to induce MKP-1 expression. In HeLa cells treated with IL-1 or IL-1 and dexamethasone, the dynamics of p38 activation mirrored the expression of MKP-1. These observations suggest that MKP-1 participates in a negative-feedback loop which regulates p38 function and that dexamethasone may inhibit proinflammatory gene expression in part by inducing MKP-1 expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12391149      PMCID: PMC134716          DOI: 10.1128/MCB.22.22.7802-7811.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  78 in total

1.  Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism.

Authors:  W Vanden Berghe; E Francesconi; K De Bosscher; M Resche-Rigon; G Haegeman
Journal:  Mol Pharmacol       Date:  1999-10       Impact factor: 4.436

2.  MKP5, a new member of the MAP kinase phosphatase family, which selectively dephosphorylates stress-activated kinases.

Authors:  A Theodosiou; A Smith; C Gillieron; S Arkinstall; A Ashworth
Journal:  Oncogene       Date:  1999-11-25       Impact factor: 9.867

3.  Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38.

Authors:  M Lasa; M Brook; J Saklatvala; A R Clark
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

4.  p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation.

Authors:  M Takekawa; M Adachi; A Nakahata; I Nakayama; F Itoh; H Tsukuda; Y Taya; K Imai
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

5.  Molecular cloning and characterization of a novel dual specificity phosphatase, MKP-5.

Authors:  T Tanoue; T Moriguchi; E Nishida
Journal:  J Biol Chem       Date:  1999-07-09       Impact factor: 5.157

6.  Dexamethasone alters arachidonate release from human epithelial cells by induction of p11 protein synthesis and inhibition of phospholipase A2 activity.

Authors:  X L Yao; M J Cowan; M T Gladwin; M M Lawrence; C W Angus; J H Shelhamer
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

7.  Cytokine mRNA decay is accelerated by an inhibitor of p38-mitogen-activated protein kinase.

Authors:  S W Wang; J Pawlowski; S T Wathen; S D Kinney; H S Lichenstein; C L Manthey
Journal:  Inflamm Res       Date:  1999-10       Impact factor: 4.575

8.  Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.

Authors:  D Hutter; P Chen; J Barnes; Y Liu
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

9.  The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism.

Authors:  R Winzen; M Kracht; B Ritter; A Wilhelm; C Y Chen; A B Shyu; M Müller; M Gaestel; K Resch; H Holtmann
Journal:  EMBO J       Date:  1999-09-15       Impact factor: 11.598

10.  Protein kinase C epsilon is required for the induction of mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages.

Authors:  A F Valledor; J Xaus; M Comalada; C Soler; A Celada
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

View more
  118 in total

1.  Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase.

Authors:  Sandip Bhattacharyya; Diane E Brown; Judson A Brewer; Sherri K Vogt; Louis J Muglia
Journal:  Blood       Date:  2007-01-25       Impact factor: 22.113

Review 2.  The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis.

Authors:  G Schett; J Zwerina; G Firestein
Journal:  Ann Rheum Dis       Date:  2007-09-07       Impact factor: 19.103

Review 3.  Role of dual specificity phosphatases in biological responses to glucocorticoids.

Authors:  Andrew R Clark; Joana R S Martins; Carmen R Tchen
Journal:  J Biol Chem       Date:  2008-06-09       Impact factor: 5.157

Review 4.  A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids.

Authors:  M A Giembycz; M Kaur; R Leigh; R Newton
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

Review 5.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

Review 6.  Minireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms.

Authors:  Jamie R Flammer; Inez Rogatsky
Journal:  Mol Endocrinol       Date:  2011-04-21

7.  Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infection.

Authors:  Zhiqiang Qin; Lu Dai; Michael Defee; Victoria J Findlay; Dennis K Watson; Bryan P Toole; Jennifer Cameron; Francesca Peruzzi; Keith Kirkwood; Chris Parsons
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

8.  Expression of glucocorticoid-induced leucine zipper (GILZ) in cardiomyocytes.

Authors:  David C Aguilar; Josh Strom; Beibei Xu; Kyle Kappeler; Qin M Chen
Journal:  Cardiovasc Toxicol       Date:  2013-06       Impact factor: 3.231

9.  The role of p44/42 activation in tributyltin-induced inhibition of human natural killer cells: effects of MEK inhibitors.

Authors:  Abraham B Abraha; Margaret M Whalen
Journal:  J Appl Toxicol       Date:  2009-03       Impact factor: 3.446

Review 10.  Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages.

Authors:  Amin Majdalawieh; Hyo-Sung Ro
Journal:  Mediators Inflamm       Date:  2010-04-12       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.